For me, the title of this book conjures up an historical image. I imagine an early 20th century consulting room, an otologist with a head mirror and bull’s eye lamp. A pre-antibiotic era in which a patient’s otorrhoea is meticulously...
Although nothing can substitute for hands-on training and time in theatre, this book is about as close as any trainee wanting to make up for training time lost to the COVID-19 pandemic, will get. Whether bought as reading for a...
Interview by Vasant Oswal of Dr Abitbol, Ancien Chef de Clinique at the University of Paris, France. Vasant Oswal Dr Abitbol Dr Abitbol developed innovative diagnostic and therapeutic techniques, which include vocal dynamic exploration to look at the vocal folds...
Mild cognitive impairment (MCI) presents a challenging frontier in healthcare due to the limited availability of effective drugs. Despite its prevalence and potential progression to dementia, there remains a notable gap in pharmacological interventions targeting MCI. This month’s Editors’ Choice...
We hear from one of the senior members of the IFOS Executive Board about the aspects of IFOS that he is looking forward to – and, in particular, his focus on implantable hearing devices. From 17 to 21 January 2023,...
Speech in noise testing provides real-life assessments of hearing that conventional pure tones cannot deliver. Rania Alkahtani describes the development of such a test for Arabic speaking children. It also has the additional benefit of being able to be delivered...
Congratulations to Gareth Smith, Audiology Editor on ENT & Audiology News, who has won the Leadership prize in the Shine Awards, which recognise the work of staff at Mid and South Essex NHS Foundation Trust in the UK.
AURITEC AT2000 is a state-of-the-art audiometer that stands out for its exceptional capabilities, especially thanks to its unique integration with cochlear implants. Designed for both clinical and research settings, the AT2000/AT-research family offers a comprehensive range of features for auditory...
Neuromod Devices Ltd., has reached an agreement with HØR AS, Norway’s largest private provider of hearing and tinnitus care, to make its Lenire tinnitus treatment device available in Norway.
Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...
When a patient is referred to a speech and language therapist for the management of swallowing difficulties, multiple options are available to address these issues. The choice is based on a detailed assessment of the patient’s swallowing physiology and function....